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Abstract
Background: In children with severe generalized cerebral palsy, pneumonias are a major health
issue. Malnutrition, dysphagia, gastro-oesophageal reflux, impaired respiratory function and
constipation are hypothesized risk factors. Still, no data are available on the relative contribution
of these possible risk factors in the described population. This paper describes the initiation of a
study in 194 children with severe generalized cerebral palsy, on the prevalence and on the impact
of these hypothesized risk factors of recurrent pneumonias.
Methods/Design: A nested case-control design with 18 months follow-up was chosen. Dysphagia,
respiratory function and constipation will be assessed at baseline, malnutrition and gastro-
oesophageal reflux at the end of the follow-up. The study population consists of a representative
population sample of children with severe generalized cerebral palsy. Inclusion was done through
care-centres in a predefined geographical area and not through hospitals. All measurements will be
done on-site which sets high demands on all measurements. If these demands were not met in "gold
standard" methods, other methods were chosen. Although the inclusion period was prolonged, the
desired sample size of 300 children was not met. With a consent rate of 33%, nearly 10% of all
eligible children in the Netherlands are included (n = 194). The study population is subtly different
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from the non-participants with regard to severity of dysphagia and prevalence rates of pneumonias
and gastro-oesophageal reflux.
Discussion: Ethical issues complicated the study design. Assessment of malnutrition and gastro-
oesophageal reflux at baseline was considered unethical, since these conditions can be easily
treated. Therefore, we postponed these diagnostics until the end of the follow-up. In order to
include a representative sample, all eligible children in a predefined geographical area had to be
contacted. To increase the consent rate, on-site measurements are of first choice, but timely
inclusion is jeopardised. The initiation of this first study among children with severe neurological
impairment led to specific, unexpected problems. Despite small differences between participants
and non-participating children, our sample is as representative as can be expected from any
population-based study and will provide important, new information to bring us further towards
effective interventions to prevent pneumonias in this population.
Background
Children with severe generalized cerebral palsy often have
a combination of motor and intellectual disabilities. They
frequently experience co-morbidity and their life expect-
ancy is low [1-11] with respiratory disease as a main cause
of death [1-3,8,10,12]. Although it is common clinical
knowledge that children with neurological impairment
often have respiratory problems [13-17], get hospitalised
for this [18] with a major impact on their quality of life
and life expectancy [14], prevalence rates have not been
studied prospectively. Retrospective prevalence estimates
of pneumonias range from 31% per 6 months; 38% single
episodes to 19% recurrent pneumonias per year [19,20].
Although several clinical specialists presume several con-
ditions to be risk factors for pneumonias, population-
based studies on this subject are lacking. Epidemiological
identification of such risk factors will bring us further
towards effective interventions to prevent pneumonias.
Hypothesized risk factors of respiratory disease in chil-
dren / adolescents with neurological impairment / intel-
lectual disabilities from the literature are listed in Table 1.
These factors may co-exist and interact with each other.
On top of this, normal childhood factors may exist, such
as asthma or passive smoking. Pneumonias can be infec-
tious or chemical of nature. To prevent pneumonias, ade-
quate function of the protection mechanisms of the
airways is essential. But in children with severe general-
ized cerebral palsy this protection system is often compro-
mised or endangered due to several conditions [14,15,20-
29]
We hypothesize that malnutrition, dysphagia, gastro-
oesophageal reflux, decreased respiratory function and
constipation are the most relevant risk factors for recur-
rent pneumonias. Since scientific evidence for a relation-
ship between these disorders and the occurrence of
pneumonias is lacking, we aim to evaluate this in a large-
scale epidemiological study. Our research questions are
the following: (1) What is the prevalence of pneumonias
in children with severe generalized cerebral palsy? (2) Are
malnutrition, dysphagia, gastro-oesophageal reflux,
decreased respiratory function and constipation risk fac-
tors for pneumonias in this group of children? The design
of the study also allows us to determine the prevalence
and presentation of the studied hypothesized risk factors.
This article describes the study design, diagnostic methods
and the study population. Attention is paid to adaptations
in the study design arising from ethical considerations as
well as from the diagnostic methods required to study
medical conditions in children with severe generalized
cerebral palsy.
Methods / Design
Study design
This study has a nested case-control design and will be
conducted in a representative group of children with
severe generalized cerebral palsy, recruited through care
centres (specialized day-care centres and residential facili-
ties) and through specialized schools. In our study popu-
lation, the hypothesized risk factors dysphagia,
respiratory function and constipation will be assessed at
Table 1: Hypothesized risk factors of pulmonary disease in 
children with neurological impairment / intellectual disabilities
recurrent aspiration (dysphagia, gastro-oesophageal reflux) [14-16, 20, 
28, 53, 54]
inefficient cough / poor cough reflex [14, 15, 28]
poor airway clearance (immobility and retained secretions) [14, 15]
respiratory muscle weakness and in-coordination [14, 15, 28]
chest wall or spinal deformities (poor pulmonary reserve) [14, 15, 28]
inadequate nutritional status (feeding problems, gastro-oesophageal 
reflux) [14, 15]
miscellaneous factors [2, 8, 10, 14-17]
bronchopulmonary dysplasia in preterm survivors
immune problems (Down's syndrome)
lipid aspiration in mineral oil treatment of constipation
reduced lung growth in skeletal dysplasias
normal childhood factors (e.g. asthma, passive smoking) [14, 15]
immobility [3, 10, 27, 28, 55, 56]BMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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baseline. However, for ethical reasons explained in the
discussion paragraph, malnutrition and gastro-oesopha-
geal reflux will be assessed at the end of the follow-up
period. Cases are defined as children with recurrent pneu-
monias, and controls as children without pneumonias
during a follow-up of 18 months. Cases and controls are
matched on age, gender and GMFCS level. A duration of
the follow-up period of 18 months was considered suffi-
cient, since we defined recurrent pneumonias as 2 or more
episodes within a year. The study will not interfere with
common medical practice and interventions in the study
population during the follow-up period. Thus, children
might be diagnosed and treated by their own physicians
during the course of the study. The study design is
depicted in Figure 1.
Setting
All diagnostic assessments in this study will be carried out
on-site at the different care centres and specialized
schools. In order to obtain a complete inclusion and
therewith a representative study population, we had to
keep the burden for the participants as small as possible.
Hospital visits were considered an obstacle for participa-
tion. Furthermore, performing measurements in a famil-
iar setting might improve cooperation of the children.
Sample size
Calculating a required sample size for this study was ham-
pered, since valid prevalence numbers of both pneumo-
nias and most of the supposed risk factors in this
population, were lacking in the literature. Prevalence
numbers were estimated based on the available literature
and on clinical experience. We calculated the required
sample size for a univariate analysis, since the number of
children required for a multivariate analysis including five
separate variables will probably be quite large. In
addition, we estimated that for logistical purposes a max-
imum number of 300 children could be included in this
study. Required sample size was calculated for each possi-
ble risk factor separately, assuming a prevalence rate of
recurrent pneumonias of 30% with a required power of
0.80 and an alpha of 0.05. The analysis for dysphagia,
based on an estimated prevalence of dysphagia of 19% in
the controls and 38% in the cases, resulted in the highest
sample size (n = 260). Assuming a loss-to-follow-up rate
of 13%, recruitment numbers were set to 300 participants.
Inclusion criteria
In this study we aimed to include children (2 to 18 years),
who have a combination of moderate to profound intel-
lectual disabilities and a severe motor disability. The intel-
lectual disability was defined as an IQ below 55 (or
estimated by dividing the developmental age by the calen-
dar age times 100). The motor disability was defined by
hypertonic or hypotonic generalized cerebral palsy or a
motor developmental delay to such an extent that a child
can at best crawl. This corresponds to a Gross Motor Func-
tion Classification Scale (GMFCS) score IV or V [30].
Study design Figure 1
Study design. In this nested case-control study, a cohort of 194 children with severe generalized cerebral palsy is followed up 
for 18 months in order to record recurrent pneumonias (2 or more episodes per year). Possible risk factors are measured 
during the follow-up. Dysphagia, constipation and pulmonary function are diagnosed at baseline, while nutritional state and gas-
tro-oesophageal reflux are diagnosed at the end of the study period.BMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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These broad criteria, resulting in a heterogeneous cohort
with regard to aetiology and disabilities, was chosen
deliberately, because in daily practice, it is this heteroge-
neous group that causes a lot of concern for parents and
physicians regarding the studied illnesses. Furthermore,
the inclusion criteria had to be clear to non-medical per-
sonnel, to ascertain they could identify the eligible
children.
Consent procedure
We approached all children with severe generalized cere-
bral palsy in a certain geographical area, an important pre-
requisite when studying a prevalence rate, to obtain a
representative sample of the total population. For prag-
matic reasons, we chose an area of 50 kilometres around
the cities of Rotterdam and Utrecht. We estimated that we
could reach 500 children in this area. With an assumed
consent rate of 0.60, this would provide the desired 300
participants. Within this area, we traced all facilities that
might provide care to children and adolescents with
severe generalized cerebral palsy, using the Dutch address
guide for disability care. These centres were contacted and
asked to participate in the study if they indeed provided
care for such children. In the participating centres, parents
or guardians of all children that met the inclusion criteria
were informed, unless children were in a critical health
status, when home situations were considered very unsta-
ble, or if parents were known to have a strong aversion to
research. Information for parents was available in Dutch,
English, and Turkish. For Moroccan families, a spoken
introductory compact disc was available, since Berber is
only a spoken language. Because gastro-oesophageal
reflux can only be measured properly using an invasive
method, parents had the opportunity to give consent with
or without this measurement.
Inclusion period
Of the 93 care centres and specialized schools that had
been contacted, 61 provided care for one or more children
with severe generalized cerebral palsy. Fifty-six of these
centres agreed to participate in our study. The other cen-
tres did not cooperate due to personnel shortage and
besides this, one centre also considered the burden of the
study for parents, children and personnel too large.
Participants
Within the participating care centres and specialized
schools, 593 children were eligible for participation. Par-
ents of 573 children were informed while the parents of 9
children were not contacted based on the previously men-
tioned reasons and 11 were not contacted because of inef-
fective internal procedures of care centres. Four children,
for whom consent was given, appeared not to meet our
inclusion criteria at first visit and were excluded. After a
prolonged inclusion period of 20 months, this resulted in
the informed consent for 194 children (consent rate of
33%). Although recruitment numbers were set to 300 par-
ticipants, we stopped the inclusion for practical reasons.
We had included nearly 10% of the Dutch population of
children with severe generalized cerebral palsy [31]. Par-
Table 2: Aetiology of disabilities
n%
Congenital diseases
Miller Dieker Syndrome / lissencephaly 7
corpus callosum agenesis 5
Cornelia de Lange syndrome 2
Walker-Warburg syndrome 2
unspecified abnormal brain development 16
other non progressive syndromes 6
other chromosomal abnormalities 9
Rett syndrome 3
Alpers syndrome 4
Aicardi-Goutieres syndrome 2
other progressive syndromes 5
other congenital diseases 4
65 33.5
Pre and perinatal complications
perinatal asphyxia 18
cerebral palsy e.c.i. 13
cerebral haemorrhage 6
intra uterine CMV infection 5
other infections 4
other causes 7
53 27.3
Acquired 
meningitis / encephalitis 5
Trauma 3
near drowning accident 2
Other 2
12 6.2
Combinations of causes
congenital and acquired disease 6
congenital disease and perinatal 
complications
5
perinatal and acquired 3
perinatal and hereditary progressive 1
15 7.7
Unknown cause
25 12.8
Missing
24 12.3
Total 
194 
childrenBMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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ents of 98 children gave consent including assessment of
gastro-oesophageal reflux (Figure 2). Because of the broad
inclusion criteria, not all children fulfilled the strict defi-
nition of cerebral palsy [32], but all children had compa-
rable disabilities. The different aetiologies of the
disabilities of the participants are depicted in Table 2.
Basic characteristics of the participants are listed in Table
3. All participating parents that gave consent preferred the
questionnaires in Dutch, even when their native language
was Turkish.
Representativeness
Global written information on children that did not par-
ticipate was obtained from parents, care centres or special-
ized schools, concerning reasons for no consent,
frequency of pneumonias, gastro-oesophageal reflux,
body mass index and diet. To our clinical experience,
parental judgement of eating skills is unreliable. Therefore
we asked which food types the child received and refor-
mulated this into a rough scale of dysphagia. Children
were categorised as severe dysphagic if they received daily
tube feeding, with or without additional oral food. Chil-
dren with dietary restrictions (liquid, solid, ground,
pureed) were categorised as having moderate dysphagia.
All other children were categorised as having "no or mild"
dysphagia.
Brief written information on children's characteristics was
acquired for 298 of the non-participants (for 169 children
from parents and for 129 children from the care centre
and school personnel). Information from 101 children
that were asked to participate (17%) is lacking. The main
reported reasons for not participating were that parents
were reluctant to any additional "hassle" with their child,
mostly because of the extended medical history. Parents
also considered the burden too large for themselves. Table
4 shows that the children that participate are slightly
younger of age, and therewith have shorter height and
lower body weight than the eligible children not partici-
pating in the study (BMI is not different between the
groups). Gender is equally distributed. According to the
parents' reports, the participating children have more
severe dysphagia, more lower respiratory infections, and
more gastro-oesophageal reflux than the non-partici-
pants.
Diagnostic methods
Diagnostic methods had to be chosen with great care.
Because all assessments are performed on-site, diagnostic
methods should be ambulatory available. Moreover,
standard methods are often not feasible, due to the sever-
ity of the handicaps of these children, and the required
level of cooperation. The Dutch ethics committee also
demanded methods to be non invasive, if possible.
Pneumonia
In clinical practice, pneumonia is diagnosed based on a
chest X-ray together with symptoms and signs. In the
present study however, we needed to use a definition that
could be used without requiring extra diagnostic proce-
dures. A previous study showed that retrospective exami-
nation of medical files was not accurate for detection of
pneumonias [33]. Therefore, the research team agreed
upon the following definition for an episode of pneumo-
nia: fever (> 38.5°C, or 1,5°C above basal temperature)
during more than 24 hours, likely due to a pneumonia,
characterized by: (increase of) dyspnoea (tachypnoea, use
of assistant respiratory muscles, wheezing) during the last
6 hours, and/or (increase of) hyper secretion of mucus,
and/or, tachypnoea and regular coughing. In addition, no
other explanation for fever (such as middle ear infection
or a urinary tract infection) should be present. Because
Table 3: Characteristics of the participants
% valid*
GMFCS score V 82.7 0.95
Can communicate "yes" and "no" 20.6 0.87
Can verbally communicate "yes" and "no" 3.1 0.87
Living with parents at home 81.4 1
Intentional movements none 34.8
little 27.9
regularly 37.7 0.66
Involuntary movements most of the day 29.6
regularly 35.2
< 2 hours a week 35.2 0.64
Seated > 3 hours / day 84.5 0.68
Standing < 30 minutes / week 38.3 0.59
Activity < 30 min / day 51.3 0.58
GMFCS = Gross Motor Function Classification Scale, *valid = fraction of the population with known informationBMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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Flow chart of inclusion period Figure 2
Flow chart of inclusion period. This figure depicts the inclusion of eligible children in the study from a predefined geographical 
area. 593 children met our inclusion criteria and parents or guardians of 573 children were informed. For several reasons, par-
ents of 20 children were not informed. For 194 children informed consent was obtained and for 98 of those with additional 
consent for assessment of gastro-oesophageal reflux. For 379 children no consent was obtained. Carers of 298 of these chil-
dren filled in a small questionnaire. Of 101 children no information was obtained.BMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
Page 7 of 11
(page number not for citation purposes)
this is a population-based study, participating children all
have their own treating physicians. To limit the number of
people that are involved in gathering data on pneumo-
nias, parents were asked to complete a questionnaire
whenever their child has a fever and airway symptoms. If
a physician is contacted, parents ask him or her to fill in a
questionnaire for physicians. Every 4 months, parents will
be reminded to complete the questionnaires if their child
was ill.
Respiratory function
The gold standard technique, spirometry, is not feasible
for this population due to the low developmental age and
motor disabilities [34]. We will measure respiratory func-
tion using the interruption technique. A reversibility test
will be done using Salbutamol. This is a well-studied tech-
nique that is commonly used in infants. Reliability is high
and the ambulatory equipment is commercially available.
[35-40] In addition, reference values are available for chil-
dren. [34,41-44]
Dysphagia
In a hospital setting, aspiration can be assessed with vide-
ofluoroscopy. Since this technique is not ambulatory
available, we will assess severity of dysphagia instead of
aspiration. For this epidemiological study we have chosen
a standardized observation method: the Dysphagia Disor-
der Survey (DDS) / Dysphagia Management Staging Scale
(DMSS). This method has been developed especially for
people with developmental disabilities [45]. We will com-
bine this method with cervical auscultation and measure-
ments of oxygen saturation, to increase accurateness of the
observation.
Constipation
To assess constipation, we will use structured parental
interviews, a two-week defecation diary and a one-week
diary on food intake. This will be combined with a physi-
cal examination of the abdomen and the anal area [46]. In
clinical practice, the physical examination also includes a
digital rectal palpation to assess faecal impaction.
However, this was considered too invasive by the ethics
committee.
Nutritional state
To assess nutritional state, we will use classical anthro-
pometry in accordance with Gerver & de Bruin [47] and
single frequency Bioelectric Impedance Assessment (BIA)
[48].
Gastro-oesophageal reflux
Gastro-oesophageal reflux will be assessed using the gold
standard method, 24-hour pH-metry [49]. However, to
make this test feasible for on-site measurements, catheter
placement will not verified by X-ray, but the step-up
method will be used [50,51].
Analysis and statistics
Incidence of pneumonia will be studied prospectively and
the prevalence of the hypothesized risk factors will be
studied cross-sectionally. The association between the
hypothesized risk factors and recurrent pneumonias will
be assessed using logistic regression. A Poisson regression
will be used to analyse their influence on pneumonia inci-
dence. In these analyses, only the cases and their controls
will be used. The required number of controls will depend
on the number of cases. P-values less than 0.05 will be
considered significant.
Table 4: Comparison of the parent-reported characteristics between the participants and non-participants
Non-participants Participants
Valid* valid*
Total number 379 194
Mean Age (years) 10.6 (4.3) 0.67 8.9 (4.4) 1
Gender (% of boys) 50.2 0.7 53.1 1
Mean Height (cm) 130.3 (21.9) 0.52 124.0 (20.1) 0.91
Median Weight (kg) 28.0 [17.0] 0.59 24.7 [16.1] 0.88
Median BMI (kg/m2) 16.4 [4.2] 0.51 15.9 [4.0] 0.85
Dysphagia severe (%) 27.3 37.8
moderate (%) 17.7 51.2
no / mild (%) 55.0 0.68 11.0 0.65
Lower respiratory tract infections (%) 16.9 0.68 27.3 0.45
recurrent** (%) 12.5 0.67 18.2 0.45
Reported gastro-oesophageal reflux (%) 25.1 44.3 0.72
Standard deviations are between brackets, inter quartile range is between square brackets, *valid = fraction of the population with known 
information, ** recurrent = two or more episodes per year, BMI = body mass index.BMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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Ethical approval
Ethical approval was obtained (P02.0188C) from the
national ethics committee (The Central Committee on
Research Involving Human Subjects). Care centres and
specialized schools formally consented to participate. Par-
ents or legal guardians gave informed consent, with or
without consent for gastro-oesophageal reflux. Because
gastro-oesophageal reflux can only be measured properly
using an invasive method, parents had the opportunity to
give consent with or without this measurement.
Discussion
Designing and conducting an epidemiological study in
children with severe generalized cerebral palsy is associ-
ated with characteristic difficulties. Even though we have
considerable experience with research through care organ-
isations [52], the initiation of this first study in children
lead to specific, not always anticipated, problems, which
caused a substantial delay. In the present study several
obstacles needed to be overcome, which will most likely
be encountered in future studies as well. This started with
the design of a realistic, ethically acceptable study, includ-
ing the choice of feasible diagnostic assessment methods
and was followed by the recruitment of a representative
cohort. In addition, one should bear in mind that on-site
measurements and therewith inclusion through care cen-
tres (specialized day-care centres and residential facilities)
and specialized schools can jeopardise timely inclusion
due to potential lengthy procedures.
Dealing with encountered obstacles
Designing the study was complicated by ethical issues,
which were resolved by a limited concession in the study
design. In standard (nested) case-control studies, hypoth-
esized risk factors are determined at baseline. In the
present study, indeed, we will determine respiratory func-
tion, constipation and dysphagia at the start of the study,
as risk factors. However, gastro-oesophageal reflux and
malnutrition are disorders that are likely to cause a con-
siderable loss of quality of life, apart from their possible
effects on pneumonias, and both can easily be treated.
Therefore, it was considered ethically unacceptable to
determine the presence of these conditions at the start of
the follow-up and then postponing treatment until the
study would be finished. For that reason, we decided to
perform the diagnostic tests for these conditions at the
end of the follow-up period. This theoretically reduces the
power of the analysis, but this reduction is relative since
both conditions have a chronic character. We consider
this design ethically acceptable, even though we pur-
posely will not assess gastro-oesophageal reflux and
nutritional state at baseline, because we will not interfere
with common medical practice. Therefore, medical diag-
nosing and treatment of these disorders will not be
hampered.
To conduct this study, a group of children with recurrent
pneumonias needed to be identified prospectively. It
would make sense to do this retrospectively. However, a
previously conducted pilot study indicated that medical
records, even when combined with interviews of paedia-
tricians and intellectual disability physicians, provided
incomplete and therefore unreliable information on
pneumonias in these children [33].
Getting informed consent of the carers of all eligible chil-
dren in a geographical area within a reasonable time span
was difficult. Firstly, there was no clear registration of the
centres that provide care for this specific population in the
Netherlands, which resulted in a search amongst a range
of organisations. Secondly, centres all had their own pro-
cedure to decide on cooperation with a study, often
including management, medical staff, other personnel,
parent boards and ethics committees. In some centres no
standard procedure existed, since they had never been
asked to participate in a study before. Thirdly, the national
ethics committee considered this study as a multi-centre
study and required a consent-form from each centre in
advance of their final approval. Although this procedure
works well in studies with 2 or 3 participating hospitals,
for the present study it meant that 56 centres needed to
decide on participation in advance. The resulting delay
was a new and unsatisfying experience for the national
ethics committee as well. Fourthly, privacy regulations
lead to great dependence on willingness and organiza-
tional skills of the participating centres. The selection of
eligible children had to be done by care centre personnel,
and information brochures were sent while researchers
were blinded for names and addresses. Despite these
encountered difficulties, we have approached a represent-
ative sample of children with severe generalized cerebral
palsy.
All diagnostic measurements should be ambulatory avail-
able and require no active cooperation. Therefore, not all
diagnostic methods in this study are "gold-standard"
methods. To date, only few diagnostic tests are available,
validated for this specific population. Some diagnostic
tests used in the present study are applied for the first time
in this population, resulting in valuable feasibility data for
future validation studies. Since ethical regulations also
required methods to be non-invasive when possible,
assessment of constipation need to be done without the
rectal digital examination, which will therefore provide
less information in comparison to the normal diagnostic
procedure.
To ensure that people of different nationalities participate
in a prevalence study, information needs to be provided
in several languages. However, our experience is that there
is no need for translated written information brochuresBMC Pediatrics 2005, 5:25 http://www.biomedcentral.com/1471-2431/5/25
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and questionnaires. A spoken introduction on compact
disc can provide an introduction and interested parents
will ask a family member for translation of the brochure
and questionnaires.
Finally, the inclusion period was stopped before target
sample size was reached, due to delay because of practical
reasons discussed above. By the end of our inclusion
period, almost a quarter of the children with severe gener-
alized cerebral palsy in the Netherlands had been
approached and nearly 10% of the Dutch population of
these children participates. Even with less power than
desired, this study will be able to put a subject on the map
that got little attention up to now.
Representativeness
To stay close to clinical practice, we used inclusion criteria
based on disabilities rather than on aetiology, resulting in
a heterogeneous group of children. Obviously, this might
also cause more heterogeneity of the results.
The participating children are slightly younger of age than
the eligible children that did not participate. However, we
do not regard an age difference of less then 2 years with a
standard deviation of over 4 years, as a clinical relevant
discrepancy. Height and weight differences can be
explained by age, since BMI is not different between both
groups. A relevant discrepancy does seem to be present
between the groups with regard to the reported severity of
dysphagia, the frequency of lower respiratory tract infec-
tions and the presence of gastro-oesophageal reflux. We
assume that the parents of the children with more severe
health problems were more likely to recognize the health
issues of their child in the information brochure and
therefore decided to participate more often. Since swal-
lowing strongly depends on motor skills, it seems likely
that participants have poorer motor skills in general then
the non-participants. Another part of the discrepancy
might be explained by the selection of non-eligible chil-
dren by staff of the centres. On first visit, we had to
exclude four children whose motor or intellectual skills
were of a higher level than those defined by our inclusion
criteria. This might also have been the case in the group
that did not consent to participate. Because of the slight
discrepancies in characteristics, the final results, especially
prevalence rates, have to be interpreted with caution.
Despite the discrepancies, our sample is as representative
as can be expected in population-based research.
Implication for future studies
Preventive medicine needs to play a major role in the
healthcare for children with severe neurological impair-
ment. Consequently, intervention studies are needed in
which effects can be measured in a valid and reproducible
way, and reference values need to be established. As in any
discipline, intervention studies should be based on epide-
miological data. To avoid complex epidemiological stud-
ies, a health register seems to be a requisite. In such a
registry, data on health status, diagnostic assessments and
applied medical treatments of children with severe neuro-
logical impairment should be recorded. This would also
enable specialists to combine knowledge and to monitor
trends.
For every study question, one should contemplate on the
choice between diagnostic assessments in hospital or on-
site. When a representative cohort of children with severe
generalized cerebral palsy is required, one should perform
a community-based study to keep the burden low and
therewith the consent rate as high as possible, but one can
expect to encounter the discussed obstacles. The main dis-
advantage of a hospital-based study is that a selective pop-
ulation will be recruited, even when performed through
an outpatient clinic. Furthermore, one should consider
that feasibility of diagnostic assessments might be better
on-site, due to the fact that the setting is familiar to the
child. On the other hand, in hospital-based studies, logis-
tics are less complicated and hospital assessments, such as
X-rays, are easily applied.
In conclusion, this study will fill in some of the lacunas in
the knowledge of the health status of these children such
as prevalence numbers of several health conditions, asso-
ciations with recurrent pneumonias. It will also provide
new information on the diagnostic tools available for
these children, and provide experience in performing sci-
entific studies in this specific field.
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